Hypha Labs Inc (DIGP)
0.033
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Hypha Labs Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2021 | -1.483 |
| September 30, 2021 | -1.810 |
| June 30, 2021 | -1.413 |
| March 31, 2021 | -1.492 |
| December 31, 2020 | -1.310 |
| September 30, 2020 | -1.620 |
| June 30, 2020 | -7.177 |
| March 31, 2020 | 8.041 |
| December 31, 2019 | 3.969 |
| September 30, 2019 | 1.546 |
| June 30, 2019 | 0.6247 |
| March 31, 2019 | 0.4032 |
| December 31, 2018 | 0.5568 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -0.1194 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | -0.5376 |
| June 30, 2013 | -0.3833 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-7.177
Minimum
Jun 2020
8.041
Maximum
Mar 2020
-0.193
Average
-1.413
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| Fonar Corp | 0.0008 |
| XWELL Inc | 0.00 |
| ProPhase Labs Inc | 0.2825 |
| Applied DNA Sciences Inc | 0.00 |
| Veracyte Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.521M |
| Total Liabilities (Quarterly) | 3.240M |
| Shareholders Equity (Quarterly) | -1.719M |